Posted in:Legal The Federal Circuit Affirms District Court Finding that Sandoz Does Not Infringe Amgen’s Protein Purification Patent By Andrew Storaska June 20, 2019 Comments are off In a recent precedential opinion, the Federal Circuit rejected arguments by Amgen that a single step purification process used by Sandoz... Read more Tagged with: aBLA, Amgen, Amgen v. Sandoz, doctrine of equivalents, FDA, Featured, Federal Circuit, Sandoz http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:Legal Federal Biosimilars Act Preempts State Law By Caitlin M. Wilmot January 2, 2018 Comments are off On December 14, 2017, the Federal Circuit issued an opinion in Amgen v. Sandoz, holding that the Biologics Price Competition and Innovation... Read more Tagged with: Amgen, Amgen v. Sandoz, BPCIA, FDA, Federal Circuit, filgrastim, Neupogen®, Sandoz http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:Legal The Supreme Court’s Decision in Amgen v. Sandoz: Clear Guidance and Open Questions for Biosimilars By Jennifer P. Nock July 21, 2017 Comments are off As we previously reported here, earlier this year the Supreme Court agreed to hear its first case arising under the Biosimilars Price... Read more Tagged with: Amgen v. Sandoz, BPCIA, Legal, Litigation, Notice Requirement, Patent Dance, Sandoz v. Amgen, Supreme Court http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:Legal Supreme Court Hears Oral Argument in Its First Biosimilar Case By C. Nichole Gifford April 28, 2017 Comments are off The Supreme Court heard oral arguments on Wednesday in its first biosimilar case. On a petition filed in Sandoz, Inc. v. Amgen, Inc., et... Read more Tagged with: Amgen v. Sandoz, BPCIA, Legal, Litigation, Notice Requirement, Patent Dance, Sandoz v. Amgen, Supreme Court http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:Legal Briefing Completed in Supreme Court’s First Biosimilar Case By Nicole DeAbrantes April 14, 2017 Comments are off As we previously reported in this post, the Supreme Court granted certiorari in its first biosimilar case on Sandoz’s petition in Sandoz,... Read more Tagged with: Amgen v. Sandoz, BPCIA, Legal, Litigation, Notice Requirement, Patent Dance, Sandoz v. Amgen, Supreme Court http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:Legal Supreme Court Grants Certiorari in First Biosimilar Case By Nicole DeAbrantes and C. Nichole Gifford January 26, 2017 Comments are off The Supreme Court has agreed to hear its first biosimilar case interpreting two provisions of the Biologics Price Competition and... Read more Tagged with: Amgen v. Sandoz, BPCIA, Legal, Litigation, Notice Requirement, Patent Dance, Sandoz v. Amgen, Supreme Court http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus